Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Mol Cancer Res. 2019 Jan 16;17(5):1075–1086. doi: 10.1158/1541-7786.MCR-18-0996

Table 3.

The association between the germline variant rs61757955 and genomic and histological variables. Patients were divided based on whether or not they had the germline variant rs61757955. Patients with the germline variant rs61757955 were more likely to have CIC mutated gliomas and the 1p/19q co-deletion

Variable Mean or Percentage
(Wild Type)
Mean or
Percentage
(Mutant)
p-value
CIC Mutated 15.9% 38.1% 0.017
1p/19q Co-deletion 25.2% 47.6% 0.038
Oligodendroglioma 33.7% 42.9% 0.475
Total Somatic Mutation Count 30.9 30.0 0.766
Percent Aneuploidy 15.1% 11.7% 0.524
Astrocytoma 38.1% 42.9% 0.651
Grade 3 53.0% 42.9% 0.497
IDH Mutated 78.1% 85.7% 0.583
1p/19q Co-deletion 25.2% 47.6% 0.038
MGMT Promoter Methylation 77.8% 81.0% 1.000
Chr 7 Gain/Chr 10 Loss 13.0% 9.5% 1.000
Expression of GRB2 (FPKM) 45.7 44.4 0.636